COVID-19 Drug Delivery Devices Market Size, Share, Trends, Growth 2032
COVID-19 Drug Delivery Devices Market By Product (Prefilled Syringes, Needle-Free Injectors, Inhalers, Patches, and Others), By Route of Administration (Parenteral, Nasal, and Dermal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026
| Market Size in 2019 | Market Forecast in 2026 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 2,232.7 Million | USD 3,901.5 Million | 8.3% | 2019 |
What is size of COVID-19 Drug Delivery Devices Market?
The COVID-19 Drug Delivery Devices Market Size was worth around USD 2,232.7 Million in 2019 and is predicted to grow to around USD 3,901.5 Million by 2026 with a compound annual growth rate (CAGR) of roughly 8.3% between 2020 and 2026.
The report covers forecast and analysis for the COVID-19 drug delivery devices market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the COVID-19 drug delivery devices market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the COVID-19 drug delivery devices market on a global as well as regional level.
In order to give the users of this report a comprehensive view on the COVID-19 drug delivery devices market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product, route of administration, distribution channels, and regional segments are benchmarked based on their market size, growth rate and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the COVID-19 drug delivery devices market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research& development, regional expansion of major participants involved in the COVID-19 drug delivery devices market on global and regional basis.
COVID-19 Drug Delivery Devices Market: Report Scope
| Report Attributes | Report Details |
|---|---|
| Report Name | COVID-19 Drug Delivery Devices Market Research Report |
| Market Size in 2019 | USD 2,232.7 Million |
| Market Forecast in 2026 | USD 3,901.5 Million |
| Growth Rate | CAGR of 8.3% |
| Number of Pages | 110 |
| Key Companies Covered | Bharat Biotech, Serum Institute of India, AstraZeneca, Johnson & Johnson, Pfizer, PharmaJet, Moderna, Novawax, Inc., and GlaxoSmithKline Plc |
| Segments Covered | By Product, By Route of Administration, By Distribution, And By Region |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
| Base Year | 2019 |
| Historical Year | 2017 to 2019 |
| Forecast Year | 2020 - 2026 |
| Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The study provides a decisive view on the COVID-19 drug delivery devices market by segmenting the market based on the product, route of administration, distribution channel, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2016 to 2026. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
Some of the leading players in the global market include
- Bharat Biotech
- Serum Institute of India
- AstraZeneca
- Johnson & Johnson
- Pfizer
- PharmaJet
- Moderna
- Novawax Inc.
- GlaxoSmithKline Plc
This report segments the global COVID-19 drug delivery devices market as follows:
By Product Analysis
- Prefilled Syringes
- Needle-Free Injectors
- Inhalers
- Patches
- Others
By Route of Administration Analysis
- Parenteral
- Nasal
- Dermal
By Distribution Channel Analysis
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table Of Content
Methodology
FrequentlyAsked Questions
These devices deliver medications for COVID-19 treatment. They ensure accurate and safe dosing
The global COVID-19 Drug Delivery Devices market is expected to be driven by the need for effective treatment administration and patient care. Demand for inhalers, injectors, and infusion devices supports market growth.
According to study, the global COVID-19 Drug Delivery Devices market size was worth around USD 2,232.7 Million in 2019 and is predicted to grow to around USD 3,901.5 Million By 2026.
The global COVID-19 Drug Delivery Devices market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 8.3% during the forecast period from 2020-2026.
The global COVID-19 Drug Delivery Devices industry is projected to be challenged by Challenges include shrinking demand and regulatory uncertainty post-pandemic.
The Opportunities include platform adaptation for other respiratory therapies, innovation in inhalation devices, and emergency preparedness will offer significant growth opportunities in the COVID-19 Drug Delivery Devices market.
Inhalers and nasal delivery systems; targeted and rapid drug administration; patient-friendly device designs are the emerging trends and innovations impacting the COVID-19 Drug Delivery Devices market.
The global COVID-19 Drug Delivery Devices market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global COVID-19 Drug Delivery Devices market are; Bharat Biotech, Serum Institute of India, AstraZeneca, Johnson & Johnson, Pfizer, PharmaJet, Moderna, Novawax, Inc., and GlaxoSmithKline Plc and others.
The report explores crucial aspects of the COVID-19 Drug Delivery Devices market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients
